IDA & IBRD total vs South Korea: Immunization, measles second dose (% of children by the nationally)
IDA & IBRD total
74.9%
in 2024
South Korea
96.0%
in 2024
IDA & IBRD total rank
28th
South Korea rank
25th
Immunization, measles second dose (% of children by the nationally) over time
- IDA & IBRD total
- South Korea
How they compare
South Korea currently reports 96.0% against 74.9% in IDA & IBRD total, a difference of 21.1%.
That makes South Korea's figure about 1.3 times IDA & IBRD total's.
Across all 25 years both countries report, South Korea has been ahead every year.
IDA & IBRD total ranks 28th and South Korea ranks 25th of 43 groups.
South Korea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA & IBRD total | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.2% | 89.0% | 64.8% | South Korea |
| 2010s | 56.6% | 96.8% | 40.2% | South Korea |
| 2020s | 71.0% | 95.4% | 24.4% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, IDA & IBRD total or South Korea?
- South Korea, at 96.0% against 74.9% in IDA & IBRD total as of 2024.
- What is the difference in immunization, measles second dose between IDA & IBRD total and South Korea?
- 21.1%, with South Korea ahead.
- How many years of comparable data are there for IDA & IBRD total and South Korea?
- 25 years are reported by both, from 2000 to 2024.
- How do IDA & IBRD total and South Korea rank globally for immunization, measles second dose?
- IDA & IBRD total ranks 28th and South Korea ranks 25th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.